Cantel Medical appoints Dr Laura Forese to its Board of Directors

– USA, NJ – CANTEL MEDICAL CORP. (NYSE: CMN) announced today the appointment of Dr. Laura Forese as a member of its Board of Directors.

Dr. Forese serves as President of NewYork-Presbyterian Healthcare System, the comprehensive network of NewYork-Presbyterian that includes multiple acute care, community hospitals, employed and affiliated physician practice relationships, ambulatory facilities and post-acute institutions. She has been responsible for the strategy and execution of the rapidly evolving network that provides significant services to patients throughout the New York Region. Dr. Forese is also Group SVP and COO for NewYork-Presbyterian/Weill Cornell where she has responsibility for all programs and operations at the academic medical center and related campuses.

Dr. Forese is board certified in orthopaedic surgery. She obtained her medical degree from Columbia College of Physicians & Surgeons and holds a management degree from the Columbia University Mailman School of Public Health. Dr. Forese received her undergraduate degree from Princeton University where she graduated summa cum laude and Phi Beta Kappa.

Charles M. Diker, Chairman of Cantel Medical, said: “We are extremely pleased to add Dr. Forese to our Board. Her extensive operational and leadership experience at one of the leading medical institutions in the country, together with her practical medical background, will make her an exceptional board member.”

About Cantel Medical Corp.

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here the original post =>